Rituximab therapy for hepatitis C virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis

E-ISSN： 2050-0904|6|2|442-443

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.6, Iss.2, 2018-02, pp. : 442-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Hepatitis C Virus-Related Arthritis

By Zuckerman E.

BioDrugs, Vol. 15, Iss. 9, 2001-09 ,pp. : 573-584

Adis International

Access to resources Recommend Favorite

Comparison of the VERSANT(TM) HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR(TM) hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy

By Germer J.J. Zein N.N. Metwally M.A. Hoskin T.L. Scott Harmsen W. Smith T.F. Patel R.

Diagnostic Microbiology and Infectious Disease, Vol. 47, Iss. 4, 2003-12 ,pp. : 615-618

Elsevier

Access to resources Recommend Favorite

Combination Therapy with Interferon- and Ribavirin for Hepatitis C: Practical Treatment Issues

By Collier J. Chapman R.

BioDrugs, Vol. 15, Iss. 4, 2001-04 ,pp. : 225-238

Adis International

Access to resources Recommend Favorite

Interferon- Therapy in Sicilian and Sardinian Polytransfused Thalassaemic Patients with Chronic Hepatitis C

By Pizzarelli G.

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 55-63

Adis International

Access to resources Recommend Favorite

Renal Biopsy Research with Implications for Therapy of Glomerulonephritis

Current Drug Therapy, Vol. 7, Iss. 4, 2012-12 ,pp. : 263-267

Bentham Science Publishers

Access to resources Recommend Favorite